Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Central Nervous System Herpes Simplex and Varicella-Zoster Virus Infections in Natalizumab-Treated Patients.
Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up.
SMC Says Yes to Lemtrada(R)a- 1/4 (alemtuzumab) 12mg IV, a New Treatment for Adults with Active Relapsing Remitting-Multiple Sclerosis (RRMS)
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway.
Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response.
Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis
Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.
Amiloride Clinical Trial In Optic Neuritis (ACTION)
Tysabri prescribing information
FDA warns about seizures linked to MS drug
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Early bilateral cystoid macular oedema secondary to fingolimod in multiple sclerosis.
Anejaculatory infertility due to multiple sclerosis.
In vitro modeling of central nervous system myelination and remyelination.
Dispositional optimism is unidimensional or bidimensional? The Portuguese revised Life Orientation Test.
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.
[Epidemiology of multiple sclerosis in the Primosky Krai and Far East regions.]
Demyelination: the role of reactive oxygen and nitrogen species.
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.
Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
Pages
« first
‹ previous
…
104
105
106
107
108
109
110
111
112
…
next ›
last »